Price$0.21-0.05 (-20.81%)
01:30 PM07:45 PM
News · 26 weeks680%
2025-12-142026-06-07
Mix3990d
- SEC Filings22(56%)
- Other9(23%)
- Offering7(18%)
- Analyst1(3%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Picard Medical Inc.SCHEDULE 13G/A - Picard Medical, Inc. (0002030617) (Subject)
- PRPicard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures — — Advancing second-generation Emperor TAH development toward a fully implantable system — TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. FDA and Health Canada, today announced the successful completion of an acute in vivo implant study series using the Company's next-generation Emperor Total Artificial Heart ("Emperor TAH" or "Emperor") Platform at the University of Arizona an
- SECPicard Medical Inc. filed SEC Form 8-K: Leadership Update8-K - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form 424B3 filed by Picard Medical Inc.424B3 - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form EFFECT filed by Picard Medical Inc.EFFECT - Picard Medical, Inc. (0002030617) (Filer)
- SECPicard Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPICARD MEDICAL, INC. Issues Letter to ShareholdersTUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. FDA and Health Canada, today issued the following letter to shareholders: Dear Shareholders, Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), the parent company of SynCardia Systems LLC, is focused on advancing life-saving technologies for patients with end-stage heart failure while building long-term value for our shareholders. That mission continues to guide our strategy, and the progress we have made since 2025 — commercially,
- SECPicard Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical / SynCardia Reports First Quarter 2026 Financial Results– Gross profit turns positive; Company executes significant debt reduction – -- Responds to NYSE American continued listing notice - TUCSON, Ariz., May 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC, ("SynCardia") maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, reported financial results for the first quarter ended March 31, 2026. "We continue to make progress across both our commercial and strategic priorities," said Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical Inc. "During and the quarter, we improved gross margin perform
- SECSEC Form S-1 filed by Picard Medical Inc.S-1 - Picard Medical, Inc. (0002030617) (Filer)
- ANALYSTH.C. Wainwright initiated coverage on Picard MedicalH.C. Wainwright initiated coverage of Picard Medical with a rating of Neutral
- SECSEC Form 10-Q filed by Picard Medical Inc.10-Q - Picard Medical, Inc. (0002030617) (Filer)
- SECPicard Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form 424B4 filed by Picard Medical Inc.424B4 - Picard Medical, Inc. (0002030617) (Filer)
- SECPicard Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical Announces Pricing of $5 Million OfferingTUCSON, Ariz., May 05, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) (the "Company"), parent company of SynCardia Systems, LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the pricing of its "reasonable best efforts" offering with certain new and existing institutional investors for the purchase and sale of (i) 16,666,667 shares of the Company's common stock, par value $0.0001 per share (or common stock equivalents in lieu thereof) (the "Common Stock"), (ii) series A common warrants to purchase up to 16,666,667 shares of Common Stock (the "Series A Common Warrants"), and (iii) series B common warrants to purc
- SECSEC Form EFFECT filed by Picard Medical Inc.EFFECT - Picard Medical, Inc. (0002030617) (Filer)
- SECAmendment: SEC Form S-1/A filed by Picard Medical Inc.S-1/A - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart TechnologyTUCSON, Ariz., April 30, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today recognized Banner Health's support in bridge-to-transplant cases, following its recent announcement highlighting the health system's experience and global leadership in total artificial heart therapy. Specifically, Banner Health, one of the nation's largest fully integrated nonprofit health systems, reported that its team has performed more than 50 implants of the SynCardia Total Artificial Heart ("STAH"), representing one of the
- SECSEC Form S-1 filed by Picard Medical Inc.S-1 - Picard Medical, Inc. (0002030617) (Filer)
- SECPicard Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026TUCSON, Ariz., April 22, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC, ("SynCardia") maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced preliminary, unaudited top-line revenues for the first quarter ended March 31, 2026. Revenue rose 79.9% to $1.1 million for the three months ended March 31, 2026, from $0.6 million for the three months ended March 31, 2025, reflecting higher utilization of the SynCardia Total Artificial Heart ("STAH") and increased driver rental income. Growth was driven by higher STAH sales, which was due to favorable
- PRPicard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in TorontoTUCSON, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC, ("SynCardia") maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced its participation in the International Society for Heart and Lung Transplantation ("ISHLT") 2026 Annual Meeting, to be held at the Metro Toronto Convention Centre in Toronto, Canada. The ISHLT Annual Meeting is a leading global forum for clinicians, researchers and industry participants focused on the treatment of advanced heart and lung failure, featuring the latest clinical data, emerging technologies
- PRPicard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children's HospitalTUCSON, Ariz., April 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today highlighted the successful use of the SynCardia Total Artificial Heart ("STAH") as a bridge to heart transplantation at Texas Children's Hospital ("Texas Children's"), supporting a 21-year-old patient through a complex re-transplant journey. Texas Children's recently featured the case of Gregory, a now 21-year-old patient who had received his first heart transplant at Texas Children's in 2017 at the age of 13 following multiple
- SECPicard Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
PMI FAQ
6 questionsWhere does PMI stock trade?
Picard Medical Inc. (PMI) is listed on AMEX.What sector and industry is PMI in?
Picard Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Picard Medical Inc. go public?
Picard Medical Inc. (PMI) completed its IPO in 2025.What are analysts saying about PMI?
Picard Medical Inc. has had 1 recent analyst action on file. The most recent action was from H.C. Wainwright: Neutral on 2026-05-18.What companies are similar to PMI?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare PMI side-by-side with any of them on Quantisnow.How can I track PMI on Quantisnow?
Quantisnow aggregates Picard Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PMI to receive live email and push alerts on every new disclosure.